Buprenorphine Hcl And Naloxone Hcl Tablet
Product Images NDC 71335-1514

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hcl And Naloxone Hcl (NDC 71335-1514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

561287c0-figure-01 (Buprenorphine And Naloxone Sublingual Tablets 1)

FDA Label Image

561287c0-figure-02 (Buprenorphine And Naloxone Sublingual Tablets 2)

FDA Label Image

Med Guide Ijmage (Buprenorphine And Naloxone Sublingual Tablets 3)

FDA Label Image

Label Image (Lbl713351514)

Label Image (Lbl713351514)
This is a package of prescription medication, likely for the treatment of opioid addiction, comparing to Suboxone 2mg/0.5mg Tab manufactured by Amneal Pharmaceuticals of NY LLC. The package contains 30 tablets, and should be stored at room temperature. The National Drug Code (NDC) for this medication is 7133515141. The package was prepared by Bryant Ranck Prepack.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.